170 results on '"Burchill S"'
Search Results
2. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data
3. Mechanism of basic fibroblast growth factor-induced cell death
4. Small Round Cell Tumor with Biphenotypic Differentiation and Variant of t(21;22)(q22;q12)
5. 7.O.08 ZOLEDRONIC ACID AS NEW ADJUVANT THERAPEUTIC AGENT FOR EWINGʼS SARCOMA
6. Alpha-melanocyte stimulating hormone and the regulation of coat colour in the mouse
7. Minimal disease monitoring by QRT–PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials#
8. PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC AGENTS AND COMBINATIONS IN ESFT ACHIEVED USING THE HOLLOW FIBRE ASSAY: P.B.005
9. UKCCG AND UKCCSG STUDY OF KARYOTYPE IN THE EWINGS SARCOMA FAMILY OF TUMOURS (ESFT): O.097
10. RAPID AND SENSITIVE INDUCTION OF P38MAPK-DEPENDENT CELL DEATH IN ESFT BY FENRETINIDE: O.072
11. Micrometastases in neuroblastoma: are they clinically important?
12. Ewing’s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities
13. ADSORPTION OF POLY(VINYL ALCOHOL) BY CLAY MINERALS
14. Eine web-basierte Plattform zur kollaborativen klinischen Forschung im Bereich der Onkologie
15. Japanese remilitarisation today
16. Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT
17. Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
18. Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours
19. Gene Expression Profiling for Discovery of Novel Markers of Minimal Disease
20. Zoledronic acid as new adjuvant therapeutic agent for Ewing's sarcoma
21. Preclinical evidence of using TRAIL in Ewing's sarcoma therapy
22. Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
23. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38MAPK activity
24. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT
25. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a qality-assurance initiative of the EORTC melanoma cooperative group
26. FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells
27. Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
28. Polymerase chain reaction detection of circulating tumour cells
29. Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells
30. Limbo
31. Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells
32. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group
33. Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood
34. Neuroblastoma cell detection by reverse transcriptase‐polymerase chain reaction (RT‐PCR) for tyrosine hydroxylase mRNA
35. Frequency of H-rasmutations in human bladder cancer detected by direct sequencing
36. Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse
37. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38MAPK activity.
38. Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma.
39. Frequency of H- ras mutations in human bladder cancer detected by direct sequencing.
40. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma
41. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA
42. Melanocyte-stimulating hormone and the regulation of tyrosinase activity in hair follicular melanocytes of the mouse
43. Melanocyte-stimulating hormone, tyrosinase activity and the regulation of eumelanogenesis and phaeomelanogenesis in the hair follicular melanocytes of the mouse
44. Contrasting levels of p21^r^a^s activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid
45. Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse
46. A Combined Cytogenetic and Molecular Approach to Diagnosis in a Case of Desmoplastic Small Round Cell Tumor with a Complex Translocation (11;22;21)
47. Effect of α-melanocyte-stimulating hormone on tyrosinase activity in hair follicular and epidermal melanocytes of the mouse
48. Regulation of tyrosinase synthesis by α-melanocyte-stimulating hormone in hair follicular melanocytes of the mouse
49. Liquid Biopsies of Patients with HIGH-RISK Neuroblastoma Disclose Exosomal miRNA Modulation after the Induction Therapy
50. Liquid Biopsies Provide Exosomal MicroRNAs as Biomarkers of the Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.